Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer
about
Stable isotope-resolved metabolomics and applications for drug developmentDesign of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersCholine-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasisCharacterization of peripheral nerve sheath tumors with 3T proton MR spectroscopy.Investigation of lipid composition of dissected sentinel lymph nodes of breast cancer patients by 7T proton MR spectroscopy.Combined MR, fluorescence and histology imaging strategy in a human breast tumor xenograft model.Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.Reproducibility of total choline/water ratios in mouse U87MG xenograft tumors by 1H-MRS.Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapyTherapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRI.Widefield optical imaging of changes in uptake of glucose and tissue extracellular pH in head and neck cancer.Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.Gadolinium-based contrast agents for magnetic resonance cancer imaging.Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer.A dual sensor for real-time monitoring of glucose and oxygen.Visualization of Fluoride Ions In Vivo Using a Gadolinium(III)-Coumarin Complex-Based Fluorescence/MRI Dual-Modal Probe.Methodological and practical challenges for personalized cancer therapies.MR evaluation of response to targeted treatment in cancer cells.A molecular imaging primer: modalities, imaging agents, and applications.Quantification in magnetic resonance spectroscopy based on semi-parametric approaches.Environmentally responsive MRI contrast agents.Polymeric 1 H MRI Probes for Visualizing Tumor In Vivo.Lactate detection in inducible and orthotopic Her2/neu mammary gland tumours in mouse modelsThe size of cytoplasmic lipid droplets varies between tumour cell lines of the nervous system: a 1H NMR spectroscopy study.Nitroxide-Based Macromolecular Contrast Agents with Unprecedented Transverse Relaxivity and Stability for Magnetic Resonance Imaging of Tumors.Hyperpolarized 13C NMR studies of glucose metabolism in living breast cancer cell cultures.In Situ Ligation of High- and Low-Affinity Ligands to Cell Surface Receptors Enables Highly Selective Recognition.Supramolecularly engineered phospholipids constructed by nucleobase molecular recognition: upgraded generation of phospholipids for drug delivery.Use of 1H and 31P HRMAS to evaluate the relationship between quantitative alterations in metabolite concentrations and tissue features in human brain tumour biopsies.Monitoring of changes in lipid profiles during PLK1 knockdown in cancer cells using DESI MS.(31) P MR spectroscopic imaging of the human prostate at 7 T: T1 relaxation times, Nuclear Overhauser Effect, and spectral characterization.
P2860
Q24629149-358A8798-008E-4590-B544-7018C628C0C8Q28235682-57F5F612-C945-46BB-9C8C-B02E5FC8C797Q30514230-A2E14D65-048F-46DB-8614-E0AF8775F1B0Q33862816-3B019FAF-B4A4-4522-9DAB-CD00542851E2Q34040176-5321F1D5-8E09-4157-9D9F-2706C942495FQ34171086-D56D9CD2-AE88-4255-9626-C8AEE3BCE237Q34201606-3E76394E-68D4-4677-AA1E-B82AE8C9AF4DQ34239921-9FFE942C-BBCE-4627-88EC-A5B15376177FQ34348175-036068B4-E4AE-4E8A-9667-9CE70AB8F850Q35148900-589AAE1C-1CEF-4A29-BB44-DFBDACF7B978Q35349316-7730E0AE-2F78-45C9-A153-2CF4911FB224Q35987985-91214B9C-0C4B-4F77-B60D-9A8224A4B2BCQ36555415-63D754BC-14B4-4108-A4D4-53343C8BBF32Q36903072-F055DBCB-C337-427A-93CF-E89BC45DDB6FQ37426043-F66D7D90-F5B8-48EE-A3CE-A46D6089A864Q37537757-08104A16-29A3-488B-BFB5-12CCAF0B5E39Q37848661-2B9794A8-66A4-41FB-9376-279D34BD82FAQ37851076-F2996EC4-526C-4C0C-99A3-5AB97F5031F6Q38005672-184FA180-39A0-4E80-AC3A-A822B21E9ED5Q38124689-6EF20580-763B-4814-B7E6-D64AC8A4390BQ38138098-1B326ED7-7F32-4A5D-8C32-82958A4B81BCQ39226290-5734DE97-0E61-4436-A5C0-2D31EC15A381Q39318919-01A04E92-2A56-4AD7-9262-46758D8A773BQ39356848-F1CE145D-7906-41C2-91C2-36A5C8998198Q41162546-270A6DE2-1927-40CC-A1FF-699351C0BC82Q43782046-7D818D33-A032-4098-9AFB-C0D1A84FFA73Q47100779-2D9B45E9-F740-4A9B-99CB-D2C4300EE233Q47141205-3ACF7CDE-D877-4C1C-AA96-992BE5CC6899Q47818014-8F4EC8D5-0325-4236-AC89-65FF991E785FQ50800787-8EE18618-5B70-4D2C-A3BF-EC715BD652F0Q51099040-6DB85828-E5D8-4740-BBE6-CAFA0A7CBD98
P2860
Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Magnetic resonance spectroscop ...... maging and diagnosis of cancer
@ast
Magnetic resonance spectroscop ...... maging and diagnosis of cancer
@en
type
label
Magnetic resonance spectroscop ...... maging and diagnosis of cancer
@ast
Magnetic resonance spectroscop ...... maging and diagnosis of cancer
@en
prefLabel
Magnetic resonance spectroscop ...... maging and diagnosis of cancer
@ast
Magnetic resonance spectroscop ...... maging and diagnosis of cancer
@en
P2093
P2860
P356
P1433
P1476
Magnetic resonance spectroscop ...... maging and diagnosis of cancer
@en
P2093
Dmitri Artemov
Kristine Glunde
Marie-France Penet
Zaver M Bhujwalla
P2860
P304
P356
10.1021/CR9004007
P577
2010-05-01T00:00:00Z